|Day Low/High||0.12 / 0.16|
|52 Wk Low/High||0.03 / 3.47|
Synchrony now has a 15 cent per share dividend.
Stock futures creep higher on Friday in a quieter end to the week after a series of bombshells rock the White House.
The autoinjector will be free for insured patients and those whose annual income is less than $100,000.
Eli Lilly and Express Scripts are seeking to avoid potential bad press over high insulin prices.
A more affordable competitor to Mylan's MYL EpiPen is set to enter the market earlier than expected, and will likely pose a threat to the autoinjector's dominance in the space.
A competitor to Mylan's MYL autoinjector, EpiPen, will hit the market sooner than expected thanks to a private pharmaceutical company, Kaleo Pharmaceuticals.
Drug companies like Merck, Pfizer and Johnson & Johnson are spending big bucks on the opposition of Proposition 61.
The pharmaceutical company announced that it will increase its patient assistance program in hopes of quelling a growing backlash over its drug pricing.
The pharma company has been increasing the price of the epinephrine injector since 2007, so why are people finally taking notice?
Senators Grassley, Blumenthal and Klobuchar demand Mylan reduce the price of its dominant treatment for life-threatening allergies.
The Pittsburgh-based pharmaceutical company has been steadily jacking up the price of the auto injectors since 2010 to bolster revenues.
Some analysts say the company could be worth a second look, though, as they expect top line growth.
FDA decision will impact Relypsa's buyout potential while Aritana won't stay this undervalued.
Oil prices below $40 means more energy companies are likely to default on loans from big Wall Street banks such as JPMorgan, Citigroup and Bank of America.
These stocks trading for less than $10 a share are poised to move higher from current levels.
Swift Energy Company (NYSE: SFY) ("Swift Energy" or the "Company") today announced that, although it has current liquidity sufficient to make the $8.
Swift Energy Company (NYSE:SFY) ("Swift Energy" or the "Company") announced today that its Board of Directors (the "Board") has adopted a net operating loss ("NOL") rights plan (the "Rights Plan") in an effort to prevent...
Swift Energy Company (NYSE:SFY) reported today its third quarter 2015 financial and operating results.
Some call today's prices the 'opportunity of a lifetime.' Are They?
Swift Energy Company (NYSE: SFY) will report its third quarter financial results on Thursday, November 5, 2015 by issuing a news release before the market opens and conducting a conference call to discuss such results on...
An increasing number of energy companies are likely to file for Chapter 11 if oil prices stay low, capital markets dry up and the banks cut back on lending.
Swift Energy Company (NYSE: SFY) announced that on August 14, 2015, the New York Stock Exchange (the "NYSE") notified the Company that it is not in compliance with the continued listing standards set forth in Sections 802.
Swift Energy Company (NYSE: SFY) reported today its second quarter 2015 financial and operating results.
Swift Energy Company (NYSE: SFY) announced today that it has retained Lazard Freres & Co.
Trade-Ideas LLC identified Swift Energy (SFY) as a weak on high relative volume candidate
KeyBanc downgraded Swift Energy (SFY) stock to ‘sector weight’ from ‘overweight.’
Here are Tuesday's top research calls, including new coverage of Boeing and Comcast.
Trade-Ideas LLC identified Swift Energy (SFY) as a strong on high relative volume candidate
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.